Leadership
General Manager, Life Sciences Solutions
Trial Interactive
Michael Smyth is the General Manager of Trial Interactive, TransPerfect's Life Sciences Solutions division. Smyth has over 17 years of experience working in the pharmaceutical clinical development industry. Prior experience includes clinical and vaccine development at Teva Pharmaceuticals, Merck, Quintiles and Premier Research managing large global phase III international trials that have resulted in the approval of products including Daytrana and Focalin for ADHD, Copaxone for Multiple Sclerosis and others. He has also spent 5 years in clinical technology and services solutions supporting life sciences companies on a global basis with a strategic goal to move towards a paperless clinical development environment. Michael consults with our pharmaceutical, biotechnology, medical device and CRO clients to determine how to most efficiently use our Trial Interactive platform to streamline clinical development processes for all stakeholders. Smyth is an active member of the Drug Information Association as well as several clinical technology forums and has spoken at industry conferences on the multicultural challenges and solutions in conducting global clinical trials.
Division President
Deal Interactive
Jordan Ellington is the President of TransPerfect's Deal Interactive division, Trial Interactive's parent company. Ellington has over 20 years of application development experience on pc-based networked platforms. Since 1993 he has developed many internal and client-facing applications for major corporate, financial services and law firms, as well as developing the extranets of three of the top twenty U.S. law firms. In 1998, he was a recipient of the American Express Chairman's Award for Quality. In 1999, he founded Deal Interactive to service the secure document hosting and collaboration needs of global businesses, and to this day, continues to drive software development and manage the day-to-day operations of the business. Through a merger between Deal Interactive and TransPerfect in 2007, Ellington joined the senior management team of TransPerfect, a world leader in business services with $150 million in revenue and over 50 offices worldwide.
Co-Founder
TransPerfect Translations International
Phil Shawe is the co-founder of one of the world's leading B-to-B providers of language and business services, TransPerfect Global, and is the President and CEO of Translations.com. From 1992 until 1999, Shawe co-managed the day-to-day operations of TransPerfect with his business partner, Elizabeth Elting, to help orchestrate the company's growth from a single office start-up to an industry leader, operating from offices in over 40 cities on four continents. Prior to founding TransPerfect, Shawe was a Financial Analyst at Chemical Bank and a Global Custody Consultant at Merrill Lynch. Shawe holds an MBA from NYU's Stern School of Business and a BS from the University of Florida where he triple majored in Finance, Marketing and Risk Management.
Co-Founder
TransPerfect Translations International
Elizabeth Elting, co-founder of TransPerfect Global, is also President and CEO of TransPerfect Translations, one of the world's leading providers of document translation that she co-founded with Phil Shawe in 1992. Elting manages TransPerfect's day-to-day operations and helped orchestrate its growth from a single office start-up to an industry leader, operating from offices in over 40 cities on four continents. Elting has been cited in The Wall Street Journal, The New York Times, and Crain's New York Business as a pioneer in addressing the growing demand for professional, high quality translation services. Elting received an MBA in Finance and International Business from New York University's Stern School of Business and a BA in Modern Languages and Literatures from Trinity College.
|
